newsfilter
← Latest News
GlobeNewswire·

Abpro's Lead Program ABP-102 Featured in Celltrion Presentation at the 44th Annual J.P. Morgan Healthcare Conference

BURLINGTON, Mass., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Abpro Holdings, Inc. (NASDAQ:ABP), a clinical-stage biotechnology company developing next-generation antibody therapeutics for solid tumors, today announced that its